News | Artificial Intelligence | November 06, 2023

Two oral presentations and five ePosters accepted by the RSNA: presenting AI advancements for chest radiograph reporting efficiency and breast cancer risk assessment 

Two oral presentations and five ePosters accepted by the RSNA: presenting AI advancements for chest radiograph reporting efficiency and breast cancer risk assessment

(from left to right) Lunit's AI-powered chest X-ray analysis solution 'Lunit INSIGHT CXR' and AI-powered mammography analysis solution 'Lunit INSIGHT MMG'


November 6, 2023 — Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, is set to unveil seven significant abstracts at the Radiological Society of North America (RSNA) 2023 Annual Meeting, taking place from November 26 to November 30 in Chicago. 

The highlighted abstracts for RSNA 2023 include: 

  • an oral presentation: Lunit's AI model redefines the efficiency of chest radiograph reporting by combining new and existing AI algorithms to filter normal chest radiographs and act as a safety net to reduce radiologists’ workload. 
  • an oral presentation: in collaboration with a Swedish research group, the accuracy and robustness metrics of Lunit INSIGHT MMG were assessed in comparison to radiologists. 
  • an ePoster: Lunit's novel, predictive AI model goes beyond traditional mammographic density by investigating mammographic parenchymal patterns and longitudinal changes as predictive markers for breast cancer risk. 
  • an ePoster: comparison of the diagnostic accuracy of radiologists with and without Lunit’s AI-powered breast cancer screening solution. 
  • an ePoster: assessment of the value of supplemental breast ultrasound and Lunit’s AI in screening mammography for women with dense breasts. 
  • an ePoster: assessment of the false-negative results of Lunit’s AI-based CADe/x in mammograms for invasive breast cancers, considering molecular subtypes. 

"Lunit is consistently backing the effectiveness of the Lunit INSIGHT suite by participating in RSNA and unveiling a spectrum of innovative research results each year at RSNA since 2016. We remain dedicated to enhancing our solutions, steering the field towards a new era of chest and breast cancer screening," said Brandon Suh, CEO of Lunit. 

Beyond abstract presentations, Lunit will further showcase its AI solutions onsite by setting up a dedicated booth (#4165) at the AI Showcase section. Visitors will have the opportunity to experience firsthand how Lunit’s AI solutions are contributing to more than 2000 medical institutions worldwide and addressing the most significant global health challenges. 

For more information: www.lunit.com 

 

Find more RSNA23 conference coverage here 

 

Related content: 

Lunit SCOPE IO Enhances Breast Cancer Analysis and Treatment by Accurately Assessing Tumor-Infiltrating Lymphocytes 

Lunit's AI-Powered Mammography Analysis Solution Achieves Comparable Diagnostic Performance with Human Readers 

STUDY VALIDATES LUNIT AI AS A GAME-CHANGER, POISED TO REPLACE ONE HUMAN READER IN BREAST CANCER SCREENING 


Related Content

News | Radiology Imaging

Jan.26, 2026 — SimonMed Imaging has unveiled an updated brand and the launch of SimonMed Longevity, a new division ...

Time January 27, 2026
arrow
News | Point-of-Care Ultrasound (POCUS)

Jan. 22, 2026 — Qure.ai has received a grant from the Gates Foundation to develop a large open-source multi-modal ...

Time January 23, 2026
arrow
News | RSNA

Jan. 22, 2026 — The nomination deadline for the 2026 RSNA Rising Star Award is approaching. The Rising Star Award is ...

Time January 22, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Jan. 20, 2026 — Hyperfine, the developer of the first FDA-cleared AI-powered portable MRI system for the brain — the ...

Time January 20, 2026
arrow
News | Mammography

Jan. 16, 2026 — Vega Imaging Informatics has announced the successful curation of the world’s largest digital breast ...

Time January 19, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — VizMark has received U.S. Food and Drug Administration FDA 510k clearance for VM1, a non-metal visual ...

Time January 19, 2026
arrow
News | Radiation Therapy

Jan. 16, 2026 — Elekta has announced that its Elekta Evo* CT-Linac has received 510(k) clearance from the U.S. Food and ...

Time January 16, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — Susan G. Komen, the world’s leading breast cancer organization commends Assemblymember Lori Wilson (D ...

Time January 16, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — iSono Health has announced the commercial launch of ATUSA, an FDA-cleared, wearable and automated 3D ...

Time January 14, 2026
arrow
Feature | Cybersecurity | Kyle Hardner

As radiology practices shift toward cloud-based platforms and integrate AI-powered tools, will practices become more ...

Time January 14, 2026
arrow
Subscribe Now